USPTO serial 78153344
ENTOCOSM
Reviewed by CopyMark Law Group
Status 601
- Filing date
- Status date
- Registration date
- —
- Examiner
- SMITH, REBECCA A
- Law office
- TMO LAW OFFICE 110 - EXAMINING ATTORNEY ASSIGNED
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with ENTOCOSM?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Brian H. Batzli
BRIAN H BATZLI MERCHANT & GOULD, PCP O BOX 2910MINNEAPOLIS, MN 55402-0910UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals and chemical substances containing arthropodic substances for use in manufacturing pharmaceutical preparations these being utilized in scientific industries | ACTIVE | — |
| 005 | Pharmaceutical preparations containing arthropodic derived substances for the treatment of human ailments, medical disorders and diseases, namely-- infectious diseases caused by bacteria, fungi, viruses, helminths, protozoa and parasites, including aids and hepatitis C; cancer including cancers of the breast, prostate, lung, colon, skin, brain, blood and erythropoietic cells (Leukemias, Myelomas); heart disease; cardiovascular disease including stroke, hypertension and atherosclerosis; neuroses and psychoses-anxiety, schizophrenia, depression, and bipolar disorder; obesity; diabetes (type 1 and type 2); asthma; hypertension; hypercholesterolemia; pain (chronic and acute); inflammation including arthritis, osteoarthritis; autoimmune diseases; psoriasis, eczema; cystic fibrosis; gastro-intestinal disease, including ulcers, helicobacter pylori infections; sexual dysfunction; ophthalmic disorders including glaucoma; immune suppression following transplantation; reproductive disorders; contraception and control of reproduction; cystic fibrosis and genetic disorders; and degenerative diseases including alzheimer's dementia | ACTIVE | — |
| 042 | Pharmaceutical drug development services for drugs containing arthropodic derived substances | ACTIVE | — |
| 044 | Pharmaceutical consultation in the field of drugs containing arthropodic derived substances | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Entocosm Pty Ltd
- Other trademarks owned by Entocosm Pty Ltd
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named ENTOCOSM
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 18, 2004 | MAB1 | ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT | — |
| Oct 18, 2004 | ABN1 | ABANDONMENT - EXPRESS MAILED | — |
| Oct 18, 2004 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Jun 29, 2004 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 25, 2004 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Jun 25, 2004 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 25, 2004 | PAPER RECEIVED | — | |
| Jun 9, 2004 | NPUB | NOTICE OF PUBLICATION | — |
| Apr 19, 2004 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 29, 2004 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 29, 2004 | PAPER RECEIVED | — | |
| Dec 2, 2003 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 31, 2003 | CFIT | CASE FILE IN TICRS | — |
| Sep 29, 2003 | 1.BD | Sec. 1(B) CLAIM DELETED | — |
| Sep 29, 2003 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 29, 2003 | PAPER RECEIVED | — | |
| Mar 25, 2003 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 12, 2003 | DOCK | ASSIGNED TO EXAMINER | — |